We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

US Unseals FCA Suit Over Lexapro, Celexa

Law360 (February 25, 2009, 12:00 AM EST) -- Federal authorities have unsealed a complaint accusing Forest Laboratories Inc. of bribing doctors to prescribe the antidepressants Celexa and Lexapro and marketing the drugs for pediatric use without approval.

The U.S. Department of Justice claims the New York pharmaceutical company violated the False Claims Act by causing thousands of false claims for the drugs to be submitted to federal health care programs, according to a civil complaint unsealed Tuesday in the U.S. District Court for the District of Massachusetts.

Medicaid and Tricare, the health care program...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.